Compositions and methods of using chondroitinase ABCI mutants

Details for Australian Patent Application No. 2006294755 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Iaci, Jennifer; Vecchione, Andrea; Markensohn, Elizabeth; Caggiano, Anthony O.

Agent Pizzeys

Pub. Number AU-B-2006294755

PCT Pub. Number WO2007/038548

Priority 60/720,628 26.09.05 US

Filing date 26 September 2006

Wipo publication date 5 April 2007

Acceptance publication date 19 April 2012

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/038548 Priority application(s): WO2007/038548

19 April 2012 Application Accepted

  Published as AU-B-2006294755

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006294756-Treatment of inflammation and vascular abnormalities of the eye

2006294746-Medical suction and irrigation device handpiece